CLINICAL_TRIALS
trial_result
· 2014-04-08
Clinical Trial Update: An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE) [Phase 1]
Summary
Phase 1 trial evaluating the safety and tolerability of NNC0114-0006 in systemic lupus erythematosus. The study has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Inflammation, Systemic Lupus Erythematosus | Phase 1 | Status: TERMINATED